Woodline Partners LP
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1784547
San Francisco, CA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,394,689
-$630,946 QoQ
Shares Held
1,509,920
-21.4% QoQ
Ownership
2.84%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#15
of 182 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. KALV ranks #34 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | QNCX |
Quince Therapeutics, Inc.
|
5,200,000 | $105,040,000 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 |
All Filings in KALV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,394,689 | 1,509,920 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,025,635 | 1,921,092 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,393,687 | 1,920,664 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,713,106 | 1,920,664 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,665,592 | 1,617,469 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,912,756 | 1,288,401 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,043,569 | 608,253 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,772,442 | 150,462 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,784,479 | 150,462 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,249,071 | 346,863 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $975,222 | 108,358 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $4,014,155 | 593,810 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,924,303 | 752,881 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,694,928 | 1,086,883 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,325,986 | 497,014 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,835,503 | 138,738 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,257,174 | 129,351 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,436,875 | 101,706 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,756,075 | 224,059 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||